RLMD
Relmada Therapeutics, Inc. · Healthcare
CEO Sergio Traversa bought $178K of Relmada Therapeutics, Inc.
Bought$178,095
$0.67Price
265,976Shares
+36%Stake
What RLMD did for a copier
- $1,000 copied at Thu, Aug 28 close, $0.77
- $2,632
- S&P 500, same days
- +0.9%
Measured over 30 trading days, to the Oct 10 close.
Sergio Traversa's record
6 other buys with 3 months of prices since 2022: on average −6.8% against the S&P 500, and 2 of 6 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Aug 26. Filed Thu, Aug 28, 12:56 PM ET, during the session. Returns use the Aug 28 close and the Oct 10 close. Not investment advice.